logo_desma

Innovation, tradition and internationality

Healthcare
and therapeutic solutions


Find Desma in your area

Experts in healthcare solutions

For more than 90 years we are taking care of people’s well-being and health. Experience and will to innovate made us a modern multinational pharmaceutical industry, solidly based in Europe with a global distribution capacity.

Who we are

An international group continuously growing, engaged in manufacturing and distributing therapeutic solutions of the highest quality standard.

Products

Our products portfolio includes more than 75 brands of medications, food supplements, medical devices and cosmetics.

Distribution

A distribution network on a global scale ensures the presence of our products in more than 50 countries worldwide.

Partnership

We are constantly open to new commercial opportunities and provide for solid partnership collaborations.

50

countries

280

products in the world

75

brands

81,0 €

million turnover

Worldwide

We work every day to develop synergies that will favour the access to products of guaranteed quality for patients and consumers in the whole world. The creation of a virtuous international network is the objective we are pursuing offering not only provision but a guarantee of continuity, collaborative skills and flexibility with regards to the needs of any specific country.

Today we reach 50 countries in the 5 continents thanks to an efficient network able to distribute and promote 280 products in various formulations.

Products & areas

Our products portfolio and the solutions is able to offer different areas of interest: respiratory system, nervous system, woman wellness and gastroenterology.

Latest news

banner_tool-acquisition.png

Press release SIT - SANOFI

SIT Laboratorio Farmaceutico (hereafter “SIT”) is pleased to announce the acquisition of established product SULMETIN from Sanofi, as a result of the agreement signed on November 8, 2022.
banner_tool-acquisition.png

Press release SIT - SANOFI

SIT Laboratorio Farmaceutico (hereafter “SIT”) is pleased to announce the acquisition of Potasion brand from Sanofi, as a result of the agreement signed on November 8, 2022.
banner_tool-acquisition.png

Press release SIT - BIAL

SIT Laboratorio Farmaceutico (hereafter “SIT”) is pleased to announce the acquisition of Natifar and Natimed brands from Laboratorios BIAL, S.A, a Spanish affiliate of BIAL Group (BIAL), as a result of the agreement signed on October 25th, 2022.
Lamberto-Pedrotti.jpg

A passion for pharmaceuticals

The magazine European Business interviews the Board of Directors Adviser Lamberto Pedrotti
banner_tool-acquisition.png

SIT Laboratorio Farmaceutico a company of DESMA HC Group Acquires LOPRESSOR, ICAZ and MIOREL from Daiichi Sankyo France

Daiichi Sankyo France and SIT Laboratorio Farmaceutico (DESMA HC Group) are pleased to announce the acquisition of LOPRESSOR, ICAZ and MIOREL by SIT Laboratorio Farmaceutico from Daiichi Sankyo France.